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a rare case report and review of the literature
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Background: Mature cystic teratomas (MCTs) are the most common germ cell tumors of the ovary. Malignant
tranformation occurs in 1-2% of these neoplasms. Although most of the malignancies arising from MCTs are
squamous cell carcinomas, adenocarcinoma of the gastrointestinal type is extremery rare. We herein present a case
of adenocarcinoma of the intestinal type arising from a MCT.
Case: A 49-year-old female underwent surgery for a left ovarian tumor. The histology of the cyst walls revealed a
MCT with a few hair shafts and a squamous layer, while another part of the tumor showed adenocarcinoma of the
intestinal type. Five years after surgery, she is alive without disease.
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Mature cystic teratomas (MCTs) are the most common
germ cell tumors of the ovary. MCTs comprise 18% of
ovarian neoplasms, and malignant teranformation occurs
in 1-2% of these neoplasms [1] . Most of the malignan-
cies arising from MCTs are squamous call carcinomas,
with adenocarcinomas comprising only 7% of the malig-
nant tumors [2]. Moreover, there have been few reports
of adenocarcinoma of the gastrointestinal type in the
ovary arising from a MCT [2-5]. We herein present a
case of ovarian adenocarcinoma of the intestinal type
arising from a MCT in a perimenopausal female, and
provide a review of the literature.
Case presentation
A 49-year-old female, gravida 5, para 3, presented with
dysuria and hematuria. Her past medical, surgical,
gynecological, and family histories were all unremarkable.
Her menstrual cycle was irregular. A bimanual pelvic
examination identified a movable mass in the left adnexal
region. Vaginal ultrasound confirmed the presence of a* Correspondence: gyn044@poh.osaka-med.ac.jp
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reproduction in any medium, provided the orpolycystic mass of 67 x 57 mm in diameter without a solid
component, suggestive of ovarian tumor (Figure 1). Asci-
tes was absent, and there were no abnormal findings of
the uterus and right adnexae. Magnetic resonance imaging
(MRI) showed a multilocular cystic mass with a fat com-
ponent (Figure 2). The serum tumor marker levels were
within the normal ranges: CA125; 20.0U/mL (normal
<35.0), CA19-9; 3.8 U/mL (normal <37.0), SCC; 1.1ng/mL
(normal <1.5), except for carcinoembrionic antigen (CEA);
6.9ng/mL (normal <5.0). The diagnosis of left ovarian
MCT was made based on these data, and laparoscopic
surgery was planned.
An exploratory laparoscopy revealed an enlarged left
ovary (80mm × 70mm). The surface of the tumor was
smooth and well-circumscribed. There was no adhe-
rence to any other pelvic organs. A small amount of as-
cites was detected, and the cytology of ascites was
negative for malignancy. A laparoscopic left salpingo-
oophorectomy was performed, and the intraoperative
diagnosis of frozen sections was suspicious of borderline
malignancy. Therefore, we changed the procedure to a
laparotomy and abdominal simple total hysterectomy,
and a right salpingo-oophorectomy and partial omen-
tectomy were carried out. The patient’s postoperative
course was uneventful. The pathological findings revealedd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 Transvaginal ultrasonography. Transvaginal
ultrasonography showed a multilocular cystic lesion without a solid
part in the pelvic cavity.
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arising from a MCT. The serum level of CEA was normal-
ized 7 days after surgery. We explained to the patient that
there was no evidence about the need for adjuvant therapy
because the disease is extremely rare. She decided not toA
C
Figure 2 MRI findings before surgery. Horizontal T2-weighted (A) and T
showed a drop in the signal intensity on fat saturated T1-weighted imagesreceive adjuvant therapy. The patient had no recurrence
of the disease as of 5 years after the surgery.
Macroscopic and microscopic evaluations
Macroscopically, the resected ovarian mass was cystic
and contained sebaceous material, hair, and calcification.
The inner surface of the mass was rough, and had partial
thicking-like nodules (Figure 3). The gross appearance of
the uterus, right adnexae and omentum were normal.
The microscopic examination of the ovarian mass
revealed that the formation contained a lot of large and
small cysts including mucin, cell debris and calcification.
The cells which formed the lumen of cysts were mostly
columnar epithelium, with some goblet cells (Figure 4).
The consistency of the small glandular cavity was high,
and severe dyskaryotic cells had become multilayered.
The nuclei were enlarged and irregularly shaped and con-
tained coarse chromatin, multidistributed and showed aty-
pia. Most nuclei had a large and brightly nucleoli. In some
areas, the malignant transformation of the intestinal epi-
thelium resulted in a well-differentiated adenocarcinoma
with stromal invasion (Figure 5).
In the immunohistochemical staining studies, CK20
(Dako) and Muc-2 (Novocastra) were positive, and CK7
(Dako), Muc-5AC (Novocastra) (Figure 6), Muc-6
(Novocastra), the ER (Dako), and the PR (Dako) (FigureB
1-weighted (B) MR imaging demonstrated a fat component, which
(C) in the multilocular cystic lesion without a solid part (arrow).
Figure 5 Microscopic findings [2]. The consistency of the small
glandular cavity was high, and severe dyskaryotic cells had become
multilayered, with stromal invasion. (H&E x200, bar = 50 μm).
Figure 3 The gross appearance of the tumor. A 3 cm slightly
yellowish solid part (arrows) was observed.
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part. Another part of the cyst wall revealed a MCT with
a few hair shafts, squamous layer and sebaceous gland
(Figure 7). There were no immature components in the
tumor.
The final diagnosis was left ovarian MCT with malig-
nant transformation and mucinous adenocarcinoma,
intestinal type, FIGO stage Ic (b).
Conclusions
Malignant transformation of MCTs has been recorded as
occurring in 1-2% of cases [1]. The most common form of
malignant transformation of MCTs is squamous cell car-
cinoma, which occurs in about 75% of cases, while adeno-
carcinoma arising from MCTs is rare, with an incidence of
7% [6]. Adenocarcinoma of the gastrointestinal type is ex-
tremely rare. The immunohistochemical analysis showed
positive staining for CK20 and Muc-2, while CK7,Figure 4 Microscopic findings [1]. The cells which formed the
lumen of cysts were mostly columnar epithelium, with some goblet
cells. (H&E x20, bar = 500 μm).Muc-5AC and Muc-6 were negative in the adenocarcino-
matous part. Therefore, we diagnosed the tumor as adeno-
carcinoma of the intestinal type arising from a MCT. To
our knowledge, only six cases of adenocarcinoma of the
gastrointestinal type arising from MCTs have been
reported in the English literature [2-7]. The relevant cli-
nical and pathological findings of these cases are summar-
ized in Table 1. The patients’ ages ranged from 37 to 77
years old (mean, 50 years). All of the cases were of stage I
disease, excluding the second patient. All patients had
undergone surgery and had been diagnosed based on the
postoperative histological findings. Two patients received
adjuvant chemotherapy, but one patient died of disease 3
months after surgery.
MCTs of the ovary represent the majority of benign
ovarian neoplasms in females younger than 30 years of
age [8], whereas malignant transformation of MCTs is
usually found in postmenopausal females. The present
case was perimenopausal and three of the six previous
cases were premenopausal. Adenocarcinoma of the
gastrointestinal type arising from MCTs may occur at a
lower age than other histological types of malignant
transformation of MCTs.
Recently, laparoscopic surgery for benign ovarian cys-
tic tumors has been performed rather than laparotomy.
However, there have been concerns about artificial
tumor rupture due to chemical peritonitis and the
spread of tumor cells. Hackethal et al. [9] reviewed and
analyzed the published data about squamous cell carci-
noma arising from MCTs of the ovary. According to
their data, unlike common ovarian carcinomas, rupture
of the tumor capsule has no adverse prognostic effects.
In the present case, we performed a laparoscopic
salpingo-oophorectomy and could not avoid the artificial
rupture of the tumor. Fortunately, our case had no
A B
C D
Figure 6 Immunohistchemical staining. CK7 (A) and Muc-5AC (C) were negative. CK20 (B) and Muc-2 (D) were positive.
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rupture of the tumor should be avoided in order to pre-
vent recurrence [9]. Furthermore, the previous analysis
revealed that while hysterectomy, bilateral salpingo-
oophorectomy and lymphadenectomy were associated
with a better outcome, omentectomy did not affect the
overall survival. This may suggest that the spreading pat-
tern of malignant transformation of MCTs differs from
that of epithelial ovarian cancer.
Several reports suggested that the SCC antigen, either
alone or in combination with other markers, such as
macrophage-colony stimulating factor (M-CSF) and car-
cinoembryonic antigen (CEA), should be considered use-
ful markers for squamous cell carcinoma arising from
MCTs for making a preoperative diagnosis [10-12]. On
the other hand, there has been no data regarding adeno-
carcinoma arising from MCTs because of the small
number of cases. However, as shown in Table 1, an ele-
vation of CEA was seen in three of the 7 cases, includingFigure 7 Microscopic cross-section through the tumor. The
tumor contained components of squamous layer, sebaceous gland
(black arrow), fat tissue (arrow head) and atypical grand (white
arrow). (H&E x4).our present case. Therefore, tumors markers may be
useful for making a preoperative diagnosis.
MCTs might occur as a result of failure of the first
meiotic division, but it is unclear how the malignant
transformation of MCTs occurs. Rim et al. [13] studied
11 cases of malignant transformation of MCTs and elu-
cidated that 80% of MCTs are diagnosed in subjects who
are of reproductive age. Based on that finding, Amanjit
et al. [14] suggested that the malignant transformation
of MCTs could be related to the long-term presence of
non-removed MCTs. However, the pathogenesis is still
unknown, and it is unclear whether malignant trans-
formation occurs separately or co-exists with carcinoma.
It is difficult to make a diagnosis of malignant trans-
formation of a MCT preoperatively. MRI findings may
be helpful to distinguish malignant transformation from
benign neoplasms. Several reports have revealed that an
important feature of the malignant transformation of
MCTs was the existence of an enhanced solid compo-
nent in MCTs [15-18]. In our case, MRI was performed
without gadolinium enhancement, therefore, it was diffi-
cult to determine whether the lesion was malignant.
When malignant transformation of MCTs is suspected
preoperatively, enhanced MRI, intraoperative consult-
ation and a postoperative histological diagnosis are very
important.
Consent
Written informed consent was obtained from the patient
for publication of this Case Report and any accompany-
ing images. A copy of the written consent is available for
review by the Editor-in-Chief of this journal.
Table 1 Preveous reports of adenocarcinoma of the gastrointestinal type in the ovary arising from a MCT







1 G.Ueda et al. (1993) 62 N.E. 35 TAH+BSO Ia FAMT 15 years
2 Fishman A et al. (1998) 38 CEA: 40 ng/ml CA 125: 80 U/ml
CA153: 60 U/ml






3 Levine DA et.al (2004) 37 CEA: 11.2 ng/ml CA 125,AFP,
HCG: WNL
15 x 12 x 11 Unilateral SO +OMT
+PLN+PAN
Ia none 40 month
4 Kushima M (2004) 52 CA19-9: 109 U/ml SLX: 58.5 U/ml
CA125: 36 U/ml CA72-4: 19 U/ml
6.4 x 4.8 x 2.8 Bilateral SO Ia none 31 month
5 KJ Min et.al (2006) 77 CA125: 72 U/ml 17 x 14 x 2 TAH+BSO Ia none 12 month





7 present case 49 CEA: 6.9 ng/ml CA 125: 20 U/ml
CA19-9: 3.8 U/ml SCC: 1.1 ng/ml
6.7 x 5.7 TAH+BSO+OMT Ic(b) none 5 years
*1 TAH: total abdominal hysterectomy, SO: salpingo-oophorectomy, OMT: omentectomy, PLN: pelvic lymphadenecomy, PAN: para aortic lymphadenectomy, *2
FAMT:5-furuorouracil+endoxan+mitomycin-C+toyomycin.
*3 N.E.: not examined *4 N.D.: no discription WNL : within normal limits.
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